Home/Filings/4/0001127602-09-025696
4//SEC Filing

AMPER LINDA E 4

Accession 0001127602-09-025696

CIK 0000729922other

Filed

Dec 17, 7:00 PM ET

Accepted

Dec 18, 4:24 PM ET

Size

9.3 KB

Accession

0001127602-09-025696

Insider Transaction Report

Form 4
Period: 2009-12-15
AMPER LINDA E
Sr. VP, Human Resources
Transactions
  • Award

    Common Stock

    2009-12-15+6,70019,663 total
  • Award

    Stock Option (Right to Buy)

    2009-12-15+20,00020,000 total
    Exercise: $35.40From: 2010-12-15Exp: 2019-12-14Common Stock (20,000 underlying)
  • Tax Payment

    Common Stock

    2009-12-16$32.89/sh562$18,48419,101 total
Footnotes (4)
  • [F1]Represents the Restricted Stock Unit component of the annual equity compensation to executive officers. 25% of the Restricted Stock Units vest one year after the date of grant and the remainder will vest ratably on an annual basis over the succeeding 3 years. The Reporting Person will receive one share of OSI Common Stock upon the vesting of each Restricted Stock Unit.
  • [F2]Reflects the withholding of shares by the Company to satisfy the tax liability upon the vesting of Restricted Stock Units.
  • [F3]25% of the option will become exerciseable one year after the date of grant and the remainder will vest ratably on an annual basis over the succeeding 3 years.
  • [F4]Includes only options with the same termination date.

Issuer

OSI PHARMACEUTICALS INC

CIK 0000729922

Entity typeother

Related Parties

1
  • filerCIK 0001220024

Filing Metadata

Form type
4
Filed
Dec 17, 7:00 PM ET
Accepted
Dec 18, 4:24 PM ET
Size
9.3 KB